Cargando…
Inhaled therapies targeting prostacyclin pathway in pulmonary hypertension due to COPD: systematic review
BACKGROUND: Pulmonary hypertension due to chronic obstructive pulmonary disease (COPD) and interstitial lung disease (ILD) is classified as group 3 pulmonary hypertension. Inhaled treprostinil, a prostaglandin I(2) analogue also known as prostacyclin, has recently been approved as a first drug for p...
Autores principales: | Alqarni, Abdullah A., Aldhahir, Abdulelah M., Bintalib, Heba M., Alqahtani, Jaber S., Siraj, Rayan A., Majrshi, Mansour, AlGarni, Abdulkareem A., Naser, Abdallah Y., Alghamdi, Sara A., Alwafi, Hassan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10496018/ https://www.ncbi.nlm.nih.gov/pubmed/37706024 http://dx.doi.org/10.3389/fmed.2023.1217156 |
Ejemplares similares
-
Role of prostanoids, nitric oxide and endothelin pathways in pulmonary hypertension due to COPD
por: Alqarni, Abdullah A., et al.
Publicado: (2023) -
Prevalence of Nomophobia and Its Impact on Academic Performance Among Respiratory Therapy Students in Saudi Arabia
por: Aldhahir, Abdulelah M, et al.
Publicado: (2023) -
Physicians’ Attitudes, Beliefs and Barriers to a Pulmonary Rehabilitation for COPD Patients in Saudi Arabia: A Cross-Sectional Study
por: Aldhahir, Abdulelah M., et al.
Publicado: (2022) -
Physicians’ Perceptions of and Barriers to Cardiopulmonary Rehabilitation for Heart Failure Patients in Saudi Arabia: A Cross-Sectional Study
por: Aldhahir, Abdulelah M., et al.
Publicado: (2022) -
Sleep Quality, Insomnia, Anxiety, Fatigue, Stress, Memory and Active Coping during the COVID-19 Pandemic
por: Alqahtani, Jaber S., et al.
Publicado: (2022)